Researchers develop adaptive fuzzy sliding mode controller to estimate unknown parameters and control nonlinear PAMs, showing improved tracking accuracy and adaptability compared to traditional methods.
SourceShibaura Institute of Technology·JournalScientific Reports·TypeExperimental study·DateAug 20, 2023
A new study by University of South Australia researchers found that boarders get 40 minutes more sleep than day students due to fixed bedtimes and stricter technology policies. Despite improved sleep, teen boarders experience similar levels of stress, anxiety, and depression as their day peers.
SourceUniversity of South Australia·JournalBritish Journal of Educational Psychology·TypeSurvey·DateAug 20, 2023
The Tiangong space station features a T-shaped configuration with three modules: Tianhe, Wentian, and Mengtian. It boasts advanced technologies, including a large-area flexible solar array system, physicochemically regenerative life support systems, and robotic arms.
SourceBeijing Institute of Technology Press Co., Ltd·JournalSpace: Science & Technology·DateAug 20, 2023
A Murdoch Children's Research Institute-led review found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents. However, with most children now having caught the SARS-CoV-2 virus and building up a natural immunity, the additional benefit of vaccination in healthy children is minimal. The review...
SourceMurdoch Childrens Research Institute·JournalBMJ Paediatrics Open·TypeLiterature review·DateAug 20, 2023
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers have discovered that estrogen promotes tumor growth in ERα-negative cancers, such as triple-negative breast cancer. Anti-estrogenic therapies, when combined with immune checkpoint inhibitors, drastically suppress tumor progression in mice models.
SourceHokkaido University·JournalBritish Journal of Cancer·TypeExperimental study·DateAug 20, 2023
Researchers at the University of Tokyo have developed a DNA-based anticoagulant that has shown promising results in test mice and may be ready for human trials soon. The treatment could provide a safer alternative to existing medications, such as heparin, which can cause severe bleeding side effects.
SourceUniversity of Tokyo·JournalMolecular Therapy·TypeExperimental study·DateAug 20, 2023